Get started
Author

Richard Boldero

Observed names: R Boldero, R. Boldero
ORCID: 0009-0001-8947-7416
Observed ORCID: 0009-0001-8947-7416
OpenAlex ID: A5014780497
A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study
2020 · Evelien Moorkens, Arnold G. Vulto, et al. · BioDrugs · 28
PDF
Prescribing by level of deprivation in Wales: an investigation of selected medicine groups
2024 · Richard Boldero, Anne Hinchliffe, et al. · Journal of Epidemiology & Community Health · 2
Medicines identified as low priority for funding: a Welsh perspective
2019 · Paul Deslandes, Richard Boldero, et al. · Journal of the Royal Society of Medicine · 2
PDF
PP89 The Investigation And Development Of A National Formulary Monitoring System Across Wales
2021 · Richard Boldero, Thomas Curran, et al. · International Journal of Technology Assessment in Health Care · 1
PDF
Introducing a new national tool to monitor the carbon footprint of inhalers
2024 · R Boldero, S Griffiths, et al. · International Journal of Pharmacy Practice
PDF
Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data
2022 · Peter N. Taylor, Qi Zhuang Siah, et al. · Diabetic Medicine
PDF
The development of a medicines stock holding tool during the COVID-19 pandemic
2021 · R. Boldero, Hugo J.A. Adams, et al. · Pharmacoepidemiology and Drug Safety
Works count: 7
Citation count: 33
H-index: 2
I10-index: 1
Year
Topic
Type